{"public_id":"cl_53fc68de81b9cd344d22bc7f873b2b2c","status":"active","superseded_by_public_id":null,"corpus_id":6888582,"text":"Best corrected visual acuity improved significantly after photodynamic therapy, with mean LogMAR decreasing from 0.33 ± 0.27 at baseline to 0.11 ± 0.18 at 3 months, 0.11 ± 0.17 at 6 months, 0.17 ± 0.26 at 12 months, and 0.10 ± 0.23 at the final visit.","confidence":0.97,"paper":{"corpus_id":6888582,"title":"Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy","url":"https://sah.borca.ai/papers/6888582"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.97,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_282da201852b7e96aa8f2834af433877","name":"LogMAR","description":"A logarithmic scale used to quantify visual acuity.","types":["measurement scale"],"url":"https://sah.borca.ai/concepts/co_282da201852b7e96aa8f2834af433877"},{"public_id":"co_6ba38885d3edc15a36a46027e8418221","name":"best corrected visual acuity","description":"The best vision a patient can achieve with optimal refractive correction, measured here in LogMAR.","types":["outcome","measurement"],"url":"https://sah.borca.ai/concepts/co_6ba38885d3edc15a36a46027e8418221"},{"public_id":"co_9c4cde4692dc3983ddd1fb9cd2b7add5","name":"half-dose verteporfin photodynamic therapy","description":"A photodynamic therapy regimen using a reduced 3 mg/m2 dose of verteporfin.","types":["treatment","method"],"url":"https://sah.borca.ai/concepts/co_9c4cde4692dc3983ddd1fb9cd2b7add5"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_53fc68de81b9cd344d22bc7f873b2b2c"}